Humana Inc. $HUM Shares Bought by State Board of Administration of Florida Retirement System

State Board of Administration of Florida Retirement System boosted its stake in shares of Humana Inc. (NYSE:HUM) by 0.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 116,905 shares of the insurance provider’s stock after buying an additional 1,000 shares during the quarter. State Board of Administration of Florida Retirement System owned 0.10% of Humana worth $28,581,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Humana by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after purchasing an additional 1,143,662 shares in the last quarter. AQR Capital Management LLC grew its holdings in Humana by 3,257.5% in the first quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock valued at $307,624,000 after purchasing an additional 1,127,973 shares during the last quarter. Leith Wheeler Investment Counsel Ltd. increased its position in shares of Humana by 661.7% in the second quarter. Leith Wheeler Investment Counsel Ltd. now owns 1,038,703 shares of the insurance provider’s stock valued at $253,942,000 after buying an additional 902,340 shares in the last quarter. Nuveen LLC purchased a new position in shares of Humana in the first quarter valued at $171,220,000. Finally, Dodge & Cox raised its stake in shares of Humana by 5.5% during the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock worth $2,845,830,000 after buying an additional 557,175 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Down 0.1%

Shares of NYSE:HUM opened at $245.77 on Friday. The stock has a 50-day simple moving average of $263.19 and a 200-day simple moving average of $256.85. The stock has a market capitalization of $29.56 billion, a P/E ratio of 18.86, a PEG ratio of 1.71 and a beta of 0.42. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. During the same period in the prior year, the company earned $4.16 EPS. The firm’s revenue was up 11.1% on a year-over-year basis. Equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana’s dividend payout ratio (DPR) is presently 33.18%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on HUM shares. The Goldman Sachs Group reduced their price target on shares of Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a report on Monday, November 24th. Barclays reduced their target price on Humana from $245.00 to $234.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Wells Fargo & Company raised their price target on Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Evercore ISI started coverage on Humana in a research report on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price objective on the stock. Finally, Wolfe Research dropped their price objective on Humana from $313.00 to $300.00 and set an “outperform” rating for the company in a research report on Thursday, November 20th. Eight investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $295.94.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.